6-Shogaol suppresses the growth of breast cancer cells by inducing apoptosis and suppressing autophagy via targeting notch signaling pathway.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 01 04 2020
revised: 03 05 2020
accepted: 20 05 2020
pubmed: 9 6 2020
medline: 2 3 2021
entrez: 8 6 2020
Statut: ppublish

Résumé

Breast cancer is one of the most commonly diagnosed cancer among women globally. Shogaol, the active constituent of many spices belonging to the Zingiberaceae family, has received wide attention among other shogaols in terms of its anticancer activity against different neoplasms. To date, its efficacy at the detailed molecular level against breast cancer has not been established. In the current study, we investigated the cytotoxic potential and the underlying molecular details of 6-shogaol against breast adenocarcinomacells (MCF-7), and breast ductal carcinoma cells (T47D). Cytotoxicity assay, cell cycle analysis. Real-time PCR (qPCR), apoptosis and autophagy techniques were used for the determination and molecular investigation of its anticancer properties. The current study shows that, Notch signaling downregulation (Hes1 and CyclinD1 genes), caused by 6-shogaol, lead to antiproliferative activity in breast cancer cells. The study further shows that treatment with 6-shogaol induced significant and time dependent cell cycle accumulation in G 6-Shogaol is a promising candidate to be considered as a treatment of breast cancer.

Identifiants

pubmed: 32505819
pii: S0753-3322(20)30494-7
doi: 10.1016/j.biopha.2020.110302
pii:
doi:

Substances chimiques

Antineoplastic Agents, Phytogenic 0
CCND1 protein, human 0
Catechols 0
Receptors, Notch 0
Transcription Factor HES-1 0
Oxaliplatin 04ZR38536J
Cyclin D1 136601-57-5
HES1 protein, human 149348-15-2
shogaol 83DNB5FIRF
Cisplatin Q20Q21Q62J

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110302

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Authors declare that there is no competing conflict of interest.

Auteurs

Azizah S Bawadood (AS)

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

Fahad A Al-Abbasi (FA)

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

Firoz Anwar (F)

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

Ali M El-Halawany (AM)

Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt; Nawah Scientific, Mokkatam, Cairo, Egypt.

Ahmed M Al-Abd (AM)

Department of Pharmaceutical Sciences, College of Pharmacy & Thumbay Research Institute for Precision Medicine, Gulf Medical University, P.O. 4184, Ajman, United Arab Emirates; Pharmacology Department, Medical Division, National Research Centre, Cairo, Egypt. Electronic address: ahmedmalabd@pharma.asu.edu.eg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH